Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GHB effects on prosocial and prosexual behavior
NCT02342366Completed
- Sponsor
- University of Zurich
- Start
- Feb 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sodium oxybate in major depressive disorder (MDD), bipolar disorder (BD) and Autism Spectrum Disorder (ASD), sponsored by University of Zurich. Primary endpoints: Sexual Arousal at 14 days and Social Cognition and Behavior at 14 days. Started Feb 2012; status: completed.
02
Drugs
sodium oxybate
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02342366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02342366.